Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA
Corresponding Author
Esther Diana Rossi
Division of Anatomic Pathology and Histology, Catholic University of Sacred Heart, “Agostino Gemelli” School of Medicine, Rome, Italy
Correspondence
Esther Diana Rossi, MIAC-Division of Anatomic Pathology and Histology, Università Cattolica del Sacro Cuore, “Agostino Gemelli” School of Medicine, Largo Francesco Vito, 00168 Rome, Italy.
Email: [email protected]
Search for more papers by this authorZubair Baloch
Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for more papers by this authorGuliz Barkan
Department of Pathology, Loyola University School of Medicine, Maywood, Illinois, USA
Search for more papers by this authorMaria Pia Foschini
Unit of Anatomic Pathology at Bellaria Hospital, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
Search for more papers by this authorDaniel Kurtycz
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
Search for more papers by this authorMarc Pusztaszeri
Division of Pathology, Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Search for more papers by this authorPhilippe Vielh
Department of Pathology, Medipath and American Hospital of Paris, Paris, France
Search for more papers by this authorWilliam C. Faquin
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for more papers by this authorCorresponding Author
Esther Diana Rossi
Division of Anatomic Pathology and Histology, Catholic University of Sacred Heart, “Agostino Gemelli” School of Medicine, Rome, Italy
Correspondence
Esther Diana Rossi, MIAC-Division of Anatomic Pathology and Histology, Università Cattolica del Sacro Cuore, “Agostino Gemelli” School of Medicine, Largo Francesco Vito, 00168 Rome, Italy.
Email: [email protected]
Search for more papers by this authorZubair Baloch
Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for more papers by this authorGuliz Barkan
Department of Pathology, Loyola University School of Medicine, Maywood, Illinois, USA
Search for more papers by this authorMaria Pia Foschini
Unit of Anatomic Pathology at Bellaria Hospital, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
Search for more papers by this authorDaniel Kurtycz
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
Search for more papers by this authorMarc Pusztaszeri
Division of Pathology, Jewish General Hospital and McGill University, Montreal, Quebec, Canada
Search for more papers by this authorPhilippe Vielh
Department of Pathology, Medipath and American Hospital of Paris, Paris, France
Search for more papers by this authorWilliam C. Faquin
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for more papers by this authorThis article has been simultaneously co-published by the Journal of the American Society of Cytopathology, Cancer Cytopathology, and Cytopathology. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Any journal citation can be used when citing this article.
Abstract
The use of standardised reporting systems for non-gynaecologic cytopathology has made enormous gains in popularity during the past decade, including for thyroid fine-needle aspiration, urine cytology, serous effusions, pancreas, lymph nodes, lung and more. In February 2018, the first edition of the Atlas of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was published. The MSRSGC defines six diagnostic fine-needle aspiration categories encompassing the spectrum of non-neoplastic, benign and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm. Since its initial publication in 2018, more than 200 studies and commentaries have been published, confirming the role of the MSRSGC. The second edition of the MSRSGC, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta-analyses, a new chapter summarising the use of salivary gland imaging, new advances in ancillary testing and updates in nomenclature.
Abstract
The second edition of the Milan System for Reporting Salivary Gland Cytopathology, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta-analyses, a new chapter summarising the use of salivary gland imaging, new advances in ancillary testing, updates in nomenclature and a guide to the practical application of the latest ancillary markers for the diagnosis of selected salivary gland fine-needle aspiration cases.
CONFLICT OF INTEREST STATEMENT
Maria Pia Foschini reports personal fees from Merck outside the submitted work. The remaining authors disclosed no conflicts of interest.
REFERENCES
- 1Faquin WC, Powers CN. Salivary gland cytopathology. Essentials in Cytopathology Series. Vol 5. Springer; 2008. doi:10.4103/1742-6413
10.4103/1742-6413 Google Scholar
- 2Jain R, Gupta R, Kudesia M, Singh S. Fine needle aspiration cytology in diagnosis of salivary gland lesions: a study with histologic comparison. Cytojournal. 2013; 10:5.
- 3Colella G, Cannavale R, Flamminio F, Foschini MP. Fine-needle aspiration cytology of salivary gland lesions: a systematic review. J Oral Maxillofac Surg. 2010; 68(9): 2146-2153. doi:10.1016/j.joms.2009.09.064
- 4Schmidt RL, Hunt JP, Hall BJ, Wilson AR, Layfield LJ. A systematic review and meta-analysis of the diagnostic accuracy of frozen section for parotid gland lesions. Am J Clin Pathol. 2011; 136(5): 729-738. doi:10.1309/ajcp2sd8rfqeuzjw
- 5 WC Faquin, ED Rossi, Z Baloch, et al., eds. The Milan System for Reporting Salivary Gland Cytopathology. Springer; 2018.
10.1007/978-3-319-71285-7 Google Scholar
- 6 AK El-Naggar, J Chan, T Takata, J Grandis, P Blootweg, eds. WHO Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Vol 9. 4th ed. IARC Press; 2022.
- 7Geiger JL, Ismaila N, Beadle B, et al. Management of salivary gland malignancy: ASCO guideline. J Clin Oncol. 2021; 39(17): 1909-1941. doi:10.1200/jco.21.00449
- 8Pusztaszeri M, Baloch Z, Vielh P, Faquin WC. Application of the Milan system for reporting risk stratification in salivary gland cytopathology. Cancer Cytopathol. 2018; 126(1): 69-70. doi:10.1002/cncy.21945
- 9Pusztaszeri M, Rossi ED, Baloch ZW, Faquin WC. Salivary gland fine needle aspiration and introduction of the Milan reporting system. Adv Anat Pathol. 2019; 26(2): 84-92. doi:10.1097/pap.0000000000000224
- 10Hughes JH, Volk EE, Wilbur DC, Cytopathology Resource Committee, College of American Pathologists. Pitfalls in salivary gland fine-needle aspiration cytology: lessons from the College of American Pathologists Interlaboratory Comparison Program in nongynecologic cytology. Arch Pathol Lab Med. 2005; 129(1): 26-31. doi:10.5858/2005-129-26-pisgfc
- 11Tyagi R, Dey P. Diagnostic problems of salivary gland tumors. Diagn Cytopathol. 2015; 43(6): 495-509. doi:10.1002/dc.23255
- 12Wei S, Layfield L, LiVolsi VA, Montone KT, Baloch ZW. Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: a comprehensive review. Diagn Cytopathol. 2017; 45(9): 820-827. doi:10.1002/dc.23716
- 13Johnson DN, Onenerk M, Krane J, et al. Cytologic grading of primary malignant salivary gland tumors: a blinded review by an international panel. Cancer Cytopathol. 2020; 128(6): 392-402. doi:10.1002/cncy.22271
- 14Rossi ED, Faquin WC, Baloch Z, et al. The Milan System for Reporting Salivary Gland Cytopathology: analysis and suggestions of initial survey. Cancer Cytopathol. 2017; 125(10): 757-766. doi:10.1002/cncy.21898
- 15Layfield LJ, Baloch ZW, Hirschowitz SL, Rossi ED. Impact on clinical follow-up of the Milan system for salivary gland cytology: a comparison with a traditional diagnostic classification. Cytopathology. 2018; 29(4): 335-342. doi:10.1111/cyt.12562
- 16Rossi ED, Baloch Z, Pusztaszeri M, Faquin W. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): an ASC-IAC–sponsored system for reporting salivary gland fine-needle aspiration. J Am Soc Cytopathol. 2018; 7(3): 111-118. doi:10.1159/000488969
- 17Barbarite E, Puram SV, Derakhshan A, Rossi ED, Faquin WC, Varvares MA. A call for universal acceptance of the Milan System for Reporting Salivary Gland Cytopathology. Laryngoscope. 2020; 130(1): 80-85. doi:10.1002/lary.27905
- 18Rossi ED, Faquin WC. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): an international effort toward improved patient care—when the roots might be inspired by Leonardo da Vinci. Cancer Cytopathol. 2018; 126(9): 756-766. doi:10.1002/cncy.22040
- 19Rossi ED, Wong LQ, Bizzarro T, et al. The impact of FNAC in the management of salivary gland lesions: institutional experiences leading to a risk-based classification scheme. Cancer Cytopathol. 2016; 124(6): 388-396. doi:10.1002/cncy.21710
- 20Griffith CC, Pai RK, Schneider F, et al. Salivary gland tumor fine needle aspiration cytology. A proposal for a risk stratification classification. Am J Clin Pathol. 2015; 143(6): 839-853. doi:10.1309/ajcpmii6osd2hsja
- 21Behaeghe M, Vander Poorten V, Hermans R, Politis C, Weynand B, Hauben E. The Milan System for Reporting Salivary Gland Cytopathology: single center experience with cell blocks. Diagn Cytopathol. 2020; 48(11): 972-978. doi:10.1002/dc.24515
- 22Maleki Z, Miller JA, Arab SE, et al. “Suspicious” salivary gland FNA: risk of malignancy and interinstitutional variability. Cancer. 2018; 126(2): 94-100. doi:10.1002/cncy.21939
- 23Viswanathan K, Sung S, Scognamiglio T, Yang GC, Siddiqui MT, Rao RA. The role of the Milan System for Reporting Salivary Gland Cytopathology: a 5-year institutional experience. Cancer Cytopathol. 2018; 126(8): 541-551. doi:10.1002/cncy.22016
- 24Wang H, Malik A, Maleki Z, et al. “Atypical” salivary gland fine needle aspiration: risk of malignancy and interinstitutional variability. Diagn Cytopathol. 2017; 45(12): 1088-1094. doi:10.1002/dc.23826
- 25Rohilla M, Singh P, Rajwanshi A, et al. Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification. Cancer Cytopathol. 2017; 125(10): 767-775. doi:10.1002/cncy.21900
- 26Thiryayi SA, Low YX, Shelton D, Narine N, Slater D, Rana DN. A retrospective 3-year study of salivary gland FNAC with categorisation using the Milan reporting system. Cytopathology. 2018; 29(4): 343-348. doi:10.1111/cyt.12557
- 27Liu H, Ljungren C, Lin F, Zarka MA, Chen L. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology. Cancer Cytopathol. 2018; 126(7): 490-497. doi:10.1002/cncy.22002
- 28Rossi ED, Faquin WC. The Milan System for Reporting Salivary Gland Cytopathology: the clinical impact so far. Considerations from theory to practice. Cytopathology. 2020; 31(3): 181-184. doi:10.1111/cyt.12819
- 29Jalaly JB, Farahani SJ, Baloch ZW. The Milan System for Reporting Salivary Gland Cytopathology: a comprehensive review of the literature. Diagn Cytopathol. 2020; 48(10): 880-889. doi:10.1002/dc.24536
- 30Maleki Z, Baloch Z, Lu R, et al. Application of the Milan system for reporting submandibular gland cytopathology: an international, multi-institutional study. Cancer Cytopathol. 2019; 127(5): 306-315. doi:10.1002/cncy.22135
- 31Lubin D, Buonocore D, Wei XJ, Cohen J, Lin O. The Milan system at Memorial Sloan Kettering: utility of the categorization system for in-house salivary gland fine-needle aspiration cytology at a comprehensive cancer center. Diagn Cytopathol. 2020; 48(3): 183-190. doi:10.1002/dc.24350
- 32Kurtycz DFI, Rossi ED, Baloch Z, et al. Milan Interobserver Reproducibility Study (MIRST): Milan system 2018. J Am Soc Cytopathol. 2020; 9(3): 116-125. doi:10.1016/j.jasc.2019.12.002
- 33Jo V, Krane J. Ancillary testing in salivary gland cytology: a practical guide. Cancer Cytopathol. 2018; 126(Suppl 8): 627-642. doi:10.1002/cncy.22010
- 34Wong KS, Marino-Enriquez A, Hornick JL, Jo VY. NR4A3 immunohistochemistry reliably discriminates acinic cell carcinoma from mimics. Head Neck Pathol. 2021; 15(2): 425-432. doi:10.1007/s12105-020-01213-4
- 35Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Gene Chromosome Cancer. 2007; 46(7): 708-715. doi:10.1002/gcc.20458
- 36Parfitt JR, McLachlin CM, Weir MM. Comparison of ThinPrep and conventional smears in salivary gland fine-needle aspiration biopsies. Cancer. 2007; 111(2): 123-129. doi:10.1002/cncr.22575
- 37Hashitani S, Urade M, Zushi Y, Segawa E, Okui S, Sakurai K. Establishment of nude mouse transplantable model of a human adenoid cystic carcinoma of the oral floor showing metastasis to the lymph node and lung. Oncol Rep. 2007; 17(1): 67-72. doi:10.3892/or.17.1.67
- 38Winnes M, Enlund F, Mark J, Stenman G. The MECT1-MAML2 gene fusion and benign Warthin's tumor: is the MECT1-MAML2 gene fusion specific to mucuepidermoid carcinoma? J Mol Diagn. 2006; 8(3): 394-395; author reply 395-396. doi:10.2353/jmoldx.2006.060020
- 39Seethala RR, LiVolsi VA, Zhang PJ, Pasha TL, Baloch ZW. Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck. 2005; 27(8): 696-702. doi:10.1002/hed.20227
- 40Chu PG, Lyda MH, Weiss LM. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology. 2001; 39(1): 9-16. doi:10.1046/j.1365-2559.2001.01105.x
- 41Ruschenburg I, Korabiowska M, Schlott T, Kubitz A, Droese M. The value of PCR technique in fine needle aspiration biopsy of salivary gland for diagnosis of low-grade B-cell lymphoma. Int J Mol Med. 1998; 2(3): 339-341. doi:10.3892/ijmm.2.3.339
- 42Moore JG, Bocklage T. Fine-needle aspiration biopsy of large-cell undifferentiated carcinoma of the salivary glands: presentation of two cases, literature review, and differential cytodiagnosis of high-grade salivary gland malignancies. Diagn Cytopathol. 1998; 19(1): 44-50. doi:10.1002/(sici)1097-0339(199807)19:1<44::aid-dc9>3.0.co;2-o
10.1002/(SICI)1097-0339(199807)19:1<44::AID-DC9>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- 43Andersson MK, Stenman G. The landscape of gene fusions and somatic mutations in salivary gland neoplasms—implications for diagnosis and therapy. Oral Oncol. 2016; 57: 63-69. doi:10.1016/j.oraloncology.2016.04.002
- 44Weinreb I. Translocation-associated salivary gland tumors: a review and update. Adv Anat Pathol. 2013; 20(6): 367-377. doi:10.1097/pap.0b013e3182a92cc3
- 45Pusztaszeri MP, García JJ, Faquin WC. Salivary gland FNA: new markers and new opportunities for improved diagnosis. Cancer Cytopathol. 2016; 124(5): 307-316. doi:10.1002/cncy.21649
- 46Pusztaszeri MP, Faquin WC. Update in salivary gland cytopathology: recent molecular advances and diagnostic applications. Semin Diagn Pathol. 2015; 32(4): 264-274. doi:10.1053/j.semdp.2014.12.008
- 47Griffith CC, Schmitt AC, Little JL, Magliocca KR. New developments in salivary gland pathology: clinically useful ancillary testing and new potentially targetable molecular alterations. Arch Pathol Lab Med. 2017; 141(3): 381-395. doi:10.5858/arpa.2016-0259-sa
- 48Griffith CC, Siddiqui MT, Schmitt AC. Ancillary testing strategies in salivary gland aspiration cytology: a practical pattern-based approach. Diagn Cytopathol. 2017; 45(9): 808-819. doi:10.1002/dc.23715
- 49Darras N, Mooney KL, Long SR. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms. J Am Soc Cytopathol. 2019; 8(3): 157-164. doi:10.1016/j.jasc.2019.01.006
- 50Foo WC, Jo VY, Krane JF. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms. Cancer Cytopathol. 2016; 124(6): 397-405. doi:10.1002/cncy.21693
- 51Evrard SM, Meilleroux J, Daniel G, et al. Use of fluorescent in-situ hybridisation in salivary gland cytology: a powerful diagnostic tool. Cytopathology. 2017; 28(4): 312-320. doi:10.1111/cyt.12427
- 52Hudson JB, Collins BT. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization. Arch Pathol Lab Med. 2014; 138(3): 403-409. doi:10.5858/arpa.2012-0736-oa
- 53Pusztaszeri MP, Sadow PM, Ushiku A, Bordignon P, McKee TA, Faquin WC. MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens. Cancer Cytopathol. 2014; 122(4): 257-265. doi:10.1002/cncy.21381
- 54Moon A, Cohen C, Siddiqui MT. MYB expression: potential role in separating adenoid cystic carcinoma (ACC) from pleomorphic adenoma (PA). Diagn Cytopathol. 2016; 44(10): 799-804. doi:10.1002/dc.23551
- 55Xu B, Haroon Al Rasheed MR, Antonescu CR, et al. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion. Histopathology. 2020; 76(3): 375-382. doi:10.1111/his.13981
- 56Skaugen JM, Seethala RR, Chiosea SI, Landau MS. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma. Cancer Cytopathol. 2021; 129(2): 104-113. doi:10.1002/cncy.22338
- 57Freiberger SN, Brada M, Fritz C, et al. SalvGlandDx—a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets. Neoplasia. 2021; 23(5): 473-487. doi:10.1016/j.neo.2021.03.008
- 58Stacchini A, Aliberti S, Pacchioni D, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014; 25(4): 231-240. doi:10.1111/cyt.12084
- 59Taverna C, Baněčková M, Lorenzon M, et al. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics. Histopathology. 2021; 79(3): 315-324. doi:10.1111/his.14251
- 60Rooper L, Sharma R, Bishop JA. Polymorphous low grade adenocarcinoma has a consistent p63+/p40− immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma. Head Neck Pathol. 2015; 9(1): 79-84. doi:10.1007/s12105-014-0554-4
- 61Hsieh MS, Lee YH, Chang YL. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hum Pathol. 2016; 56: 134-142. doi:10.1016/j.humpath.2016.05.021
- 62Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Histopathology. 2017; 71(4): 511-521. doi:10.1111/his.13246
- 63Rooper LM, Lombardo KA, Oliai BR, Ha PK, Bishop JA. MYB RNA in situ hybridization facilitates sensitive and specific diagnosis of adenoid cystic carcinoma regardless of translocation status. Am J Surg Pathol. 2021; 45(4): 488-497. doi:10.1097/pas.0000000000001616
- 64Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol. 2003; 16(12): 1224-1231. doi:10.1097/01.mp.0000096046.42833.c7
- 65Jo VY, Sholl LM, Krane JF. Distinctive patterns of CTNNB1 (β-catenin) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am J Surg Pathol. 2016; 40(8): 1143-1150. doi:10.1097/pas.0000000000000669
- 66Schmitt AC, Griffith CC, Cohen C, Siddiqui MT. LEF-1: diagnostic utility in distinguishing basaloid neoplasms of the salivary gland. Diagn Cytopathol. 2017; 45(12): 1078-1083. doi:10.1002/dc.23820
- 67Schmitt AC, McCormick R, Cohen C, Siddiqui MT. DOG1, p63, and S100 protein: a novel immunohistochemical panel in the differential diagnosis of oncocytic salivary gland neoplasms in fine-needle aspiration cell blocks. J Am Soc Cytopathol. 2014; 3(6): 303-308. doi:10.1016/j.jasc.2014.06.001
- 68Schmitt AC, Cohen C, Siddiqui MT. Expression of SOX10 in salivary gland oncocytic neoplasms: a review and a comparative analysis with other immunohistochemical markers. Acta Cytol. 2015; 59(5): 384-390. doi:10.1159/000441890
- 69Nakaguro M, Tanigawa M, Hirai H, et al. The diagnostic utility of RAS Q61R mutation-specific immunohistochemistry in epithelial-myoepithelial carcinoma. Am J Surg Pathol. 2021; 45: 885-894. doi:10.1097/pas.0000000000001673
- 70Pisapia P, Pepe F, Sgariglia R, et al. Next generation sequencing in cytology. Cytopathology. 2021; 32(5): 588-595. doi:10.1111/cyt.12974
Citing Literature
